In this study, obesity induced T2DM mice that received chronic administration of our novel GPR119 agonist, HD0471953, showed improved insulin sensitivity and glycemic control without severe hypoglycemia. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.